Belgian rare diseases plan in clinical pathology : identification of key biochemical diagnostic tests and establishment of reference laboratories and financing conditions

BackgroundOne objective of the Belgian Rare Diseases plan is to improve patients' management using phenotypic tests and, more specifically, the access to those tests by identifying the biochemical analyses used for rare diseases, developing new financing conditions and establishing reference laboratories.MethodsA feasibility study was performed from May 2015 until August 2016 in order to select the financeable biochemical analyses, and, among them, those that should be performed by reference laboratories. This selection was based on an inventory of analyses used for rare diseases and a survey... Mehr ...

Verfasser: Vandevelde, Nathalie M.
Vermeersch, Pieter
Devreese, Katrien
Vincent, Marie-Françoise
Gulbis, Béatrice
Eyskens, François
Boemer, François
Gothot, André
Van Hoof, Viviane O.
Bonroy, Carolien
Stepman, Hedwig
Martens, Geert A.
Bossuyt, Xavier
Roosens, Laurence
Smet, Julie
Laeremans, Hilde
Weets, Ilse
Minon, Jean-Marc
Vernelen, Kris
Coucke, Wim
Advisory Board of the Action 1 of the Belgian National Plan for Rare Diseases, missing
Dokumenttyp: journalarticle
Erscheinungsdatum: 2021
Schlagwörter: Medicine and Health Sciences / Genetics(clinical) / Pharmacology (medical) / General Medicine / Rare diseases / Clinical pathology / Financing / Reference laboratories / Reimbursement codes / Expertise
Sprache: Englisch
Permalink: https://search.fid-benelux.de/Record/base-26529157
Datenquelle: BASE; Originalkatalog
Powered By: BASE
Link(s) : https://biblio.ugent.be/publication/8703939